Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Advertising Research Needs FDA Funding, Marketing Coalition Says

Executive Summary

FDA should establish a grants program to fund research on risk presentation in direct-to-consumer advertising, a coalition of marketing and media organizations says

You may also be interested in...



DTC Effect On Patient Benefit, Compliance Needs More Study – FDA’s Temple

The effect of direct-to-consumer advertising on patient behavior needs to be further studied, FDA Center for Drug Evaluation & Research Office of Medical Policy Director Robert Temple, MD, suggested

FDA Readies Report On DTC, Says Physician Survey Supports Current Policy

FDA expects to publish a report on its 1997 direct-to-consumer broadcast advertising policy this spring

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel